|
DrugDev.org groups help you work better with colleagues and study team members. Join groups for studies that you're involved with, or create a new one...
Looking for groups? Have you seen these ones...
|
|
Extension 1 to Protocol CSPP100A2340: Study to Evaluate the Efficacy and Safety of Aliskiren on the Prevention of Left Ventricular Remodeling in High Risk Post-Acute Myocardial Infarction Patients When Added to Optimized Standard Therapy
A 2 Year Extension to a 36-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aliskiren on the Prevention of Left Ventricular Remodeling in High Risk Post-Acute Myocardial Infarction Patients When Added to Optimized Standard Therapy
(NOVARTIS)
|
join |
|
|
Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients (ANRS 140 DREAM)
A 2-year multicenter, phase II/III, randomized active-controlled trial to evaluate the efficacy and tolerance of two maintenance strategies in HIV-1 infected patients with HIV RNA below 50 copies/mL : a monotherapy with lopinavir/ritonavir or a single-tablet triple therapy (EFV/FTC/TDF).
(Abbott)
|
join |
|
|
Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-Year Period in Patients With Schizophrenia
A 2-Year, Prospective, Blinded-Rater, Open-Label, Active-Controlled, Multicenter, Randomized Study of Long-Term Efficacy and Effectiveness Comparing Risperdal Consta and Abilify (Aripiprazole) in Adults With Schizophrenia
(JOHNSON & JOHNSON PHARMACEUTICAL RES)
|
join |
|
|
Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-Year Period in Patients With Schizophrenia
A 2-Year, Prospective, Blinded-Rater, Open-Label, Active-Controlled, Multicenter, Randomized Study of Long-Term Efficacy and Effectiveness Comparing Risperdal Consta and Abilify (Aripiprazole) in Adults With Schizophrenia
(JOHNSON & JOHNSON PHARMACEUTICAL RES)
|
join |
|
|
Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-Year Period in Patients With Schizophrenia
A 2-Year, Prospective, Blinded-Rater, Open-Label, Active-Controlled, Multicenter, Randomized Study of Long-Term Efficacy and Effectiveness Comparing Risperdal Consta and Abilify (Aripiprazole) in Adults With Schizophrenia
(JOHNSON & JOHNSON PHARMACEUTICAL RES)
|
join |
|
|
Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-Year Period in Patients With Schizophrenia
A 2-Year, Prospective, Blinded-Rater, Open-Label, Active-Controlled, Multicenter, Randomized Study of Long-Term Efficacy and Effectiveness Comparing Risperdal Consta and Abilify (Aripiprazole) in Adults With Schizophrenia
(JOHNSON & JOHNSON PHARMACEUTICAL RES)
|
join |
|
|
Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
A 24 Month, Multicenter, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
(NOVARTIS)
|
join |
|
|
Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-Daily 10 cm Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (MMSE10-26)
(NOVARTIS)
|
join |
|
|
Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD)
A 24 Week, Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of 18 MCG of Tiotropium Inhalation Capsues Administered by HandiHaler Once-Daily Plus PRN Albuterol (Salbutamol) vs. Placebo Plus PRN Albuterol (Salbutamol) in Chronic Obstructive Pulmonary Diseas Subjects Naive to Meanitenance Therapy
(BOEHRINGER INGELHEIM PHARMACEUTICALS)
|
join |
|
|
Type 2 Diabetes Management With Lantus (Malbec: Manejo Con Lantus de Diabeticos Tipo 2)
A 24 Weeks, Randomized, 2 Arms, Controlled, Multi-Centre, National, Open-Labeled, Parallel Study in Insulin naive Patients With Type 2 Diabetes to Compare a Lantus Titration Algorithm vs. Physician's Standard Practice
(SANOFI-AVENTIS)
|
join |
= private group (only members can view)
|
